The meeting drew 5 thousand delegates from 77 countries.
Device certificates will expire within two to four years, depending on the risk class.
Subspecialty programs include glaucoma, refractive, cornea days.
PC-IOLs will be a main focus of the meeting, while FLACS will undergo another round of debate.
Richard Lindstrom, MD, developed the formulation.
The latest brouhaha followed a crackdown at private hospitals and a newspaper’s investigative series on private hospitals billing patients for new surgical instruments while reusing disposable ones.
The company plans to launch the lens in mid-2017.
Product candidate showed improvement in signs and symptoms of dry eye in small Phase II trial.
The next-generation system builds on the Stellaris PC, a dual-function cataract/vitrectomy machine commercialized in 2010.
The patent protects an aphakic IOL that focuses light on three focal points for near, intermediate, and distance vision.
The firm let go about 80 percent of its workforce as funding sources failed to materialize.
Glaukos will pay $5.5 million in cash, plus potential milestone payments up to $9.5 million.
Mazzo’s legal team contends that the government has not produced sufficient evidence of guilt on any of the charges levied against him.
Study suggests size of foveal avascular zone could be predictor.
EVEREST-2 study suggests combo therapy improves vision and reduces injections.
Biomarkers and antimicrobials were among products that surgeons would like to see developed.
Growth over the next five years is expected to come from increasing demand for the latest technology.
In revenue terms, the largest submarkets are cataract surgery and diagnostic equipment.
The device is designed for glaucoma patients who need regular IOP self-monitoring.
You are not currently logged in.
©2017 Market Scope
Lost your Password